The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women

References

• Bhavnani BR, Strickler RC. Menopausal hormone therapy. J Obstet Gynaecol Can 2005;27:137–162.
   PubMedGoogle Scholar
• Castelo-Branco C, Rostro F. Management of menopause. Minerva Ginecol 2006;58:137–152.
   PubMedGoogle Scholar
• Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, et al.; Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–333.
   PubMed Web of Science ®Google Scholar
• Blümel JE, Castelo-Branco C, Chedraui PA, Binfa L, Dowlani B, Gómez MS, Sarrá S. Patients’ and clinicians’ attitudes after the Women’s Health Initiative study. Menopause 2004;11:57–61.
   PubMed Web of Science ®Google Scholar
• Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women’s Health Initiative on women’s decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225–1232.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Chedraui P, Gilbert JJ, Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women’s Health Initiative era. Fertil Steril 2009;92:1171–1186.
   PubMed Web of Science ®Google Scholar
• Lazar F Jr, Costa-Paiva L, Morais SS, Pedro AO, Pinto-Neto AM. The attitude of gynecologists in São Paulo, Brazil 3 years after the Women’s Health Initiative study. Maturitas 2007;56:129–141.
   PubMed Web of Science ®Google Scholar
• Nassar AH, Abd Essamad HM, Awwad JT, Khoury NG, Usta IM. Gynecologists’ attitudes towards hormone therapy in the post “Women’s Health Initiative” study era. Maturitas 2005;52:18–25.
   PubMed Web of Science ®Google Scholar
• Miksicek RJ. Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 1993;44:37–43.
   PubMed Web of Science ®Google Scholar
• Miksicek RJ. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 1994;49:153–160.
   PubMed Web of Science ®Google Scholar
• Dornstauder E, Jisa E, Unterrieder I, Krenn L, Kubelka W, Jungbauer A. Estrogenic activity of two standardized red clover extracts (Menoflavon) intended for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol 2001;78:67–75.
   PubMed Web of Science ®Google Scholar
• Simoncini T, Fornari L, Mannella P, Caruso A, Garibaldi S, Baldacci C, Genazzani AR. Activation of nitric oxide synthesis in human endothelial cells by red clover extracts. Menopause 2005;12:69–77.
   PubMed Web of Science ®Google Scholar
• Simoncini T, Garibaldi S, Fu XD, Pisaneschi S, Begliuomini S, Baldacci C, Lenzi E, et al. Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells. Menopause 2008;15:542–550.
   PubMed Web of Science ®Google Scholar
• Mueller M, Jungbauer A. Red clover extract: a putative source for simultaneous treatment of menopausal disorders and the metabolic syndrome. Menopause 2008;15:1120–1131.
   PubMed Web of Science ®Google Scholar
• Adaikan PG, Srilatha B, Wheat AJ. Efficacy of red clover isoflavones in the menopausal rabbit model. Fertil Steril 2009;92:2008–2013.
   PubMed Web of Science ®Google Scholar
• Imhof M, Gocan A, Reithmayr F, Lipovac M, Schimitzek C, Chedraui P, Huber J. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas 2006;55:76–81.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Hidalgo L, San Miguel G, Morocho N, Ross S. Red clover extract (MF11RCE) supplementation and postmenopausal vaginal and sexual health. Int J Gynaecol Obstet 2006;95:296–297.
   PubMed Web of Science ®Google Scholar
• Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel G. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study. Gynecol Endocrinol 2005;21:257–264.
   PubMed Web of Science ®Google Scholar
• Chedraui P, San Miguel G, Hidalgo L, Morocho N, Ross S. Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index. Gynecol Endocrinol 2008;24:620–624.
   PubMed Web of Science ®Google Scholar
• Lipovac M, Chedraui P, Gruenhut C, Gocan A, Stammler M, Imhof M. Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts. Maturitas 2010;65:258–261.
   PubMed Web of Science ®Google Scholar
• Kupperman HS, Wetchler BB, Blatt MH. Contemporary therapy of the menopausal syndrome. J Am Med Assoc 1959;171:1627–1637.
   PubMed Web of Science ®Google Scholar
• Schonberg MA, Wee CC. Menopausal symptom management and prevention counseling after the Women’s Health Initiative among women seen in an internal medicine practice. J Womens Health (Larchmt) 2005;14:507–514.
   PubMed Web of Science ®Google Scholar
• Coon JT, Pittler MH, Ernst E. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis. Phytomedicine 2007;14:153–159.
   PubMed Web of Science ®Google Scholar
• de Cremoux P, This P, Leclercq G, Jacquot Y. Controversies concerning the use of phytoestrogens in menopause management: bioavailability and metabolism. Maturitas 2010;65:334–339.
   PubMedGoogle Scholar
• Nachtigall LE, Baber RJ, Barentsen R, Durand N, Panay N, Pitkin J, van de Weijer PH, Wysocki S. Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approach. J Obstet Gynaecol Can 2006;28:279–289.
   PubMedGoogle Scholar
• Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, et al.; for the Collaborative Group for Research of the Climacteric in Latin America (REDLINC). A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause 2011;18:778–785.
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Pepe A. Vasomotor symptoms and cardiovascular risk. Climacteric 2009;12 Suppl 1:32–35.
   PubMed Web of Science ®Google Scholar
• Pinkerton JV, Stovall DW. Is there an association between vasomotor symptoms and both low bone density and cardiovascular risk? Menopause 2009;16:219–223.
   PubMed Web of Science ®Google Scholar
• Giorno CD, Fonseca AM, Bagnoli VR, Assis JS, Soares Jr JM, Baracat EC. [Effects of Trifolium pratense on the climacteric and sexual symptoms in postmenopause]. Rev Assoc Med Bras 2010;56:558–562.
   PubMedGoogle Scholar
• Jacobs A, Wegewitz U, Sommerfeld C, Grossklaus R, Lampen A. Efficacy of isoflavones in relieving vasomotor menopausal symptoms - A systematic review. Mol Nutr Food Res 2009;53:1084–1097.
   PubMed Web of Science ®Google Scholar
• Kelley KW, Carroll DG. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women. J Am Pharm Assoc (2003) 2010;50:e106–e115.
   Google Scholar
• Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2007;CD001395.
   Google Scholar
• Leclercq G, de Cremoux P, This P, Jacquot Y. Lack of sufficient information on the specificity and selectivity of commercial phytoestrogens preparations for therapeutic purposes. Maturitas 2011;68:56–64.
   PubMedGoogle Scholar
• Reiter E, Beck V, Medjakovic S, Mueller M, Jungbauer A. Comparison of hormonal activity of isoflavone-containing supplements used to treat menopausal complaints. Menopause 2009;16:1049–1060.
   PubMed Web of Science ®Google Scholar
• Booth NL, Overk CR, Yao P, Burdette JE, Nikolic D, Chen SN, Bolton JL, et al. The chemical and biologic profile of a red clover (Trifolium pratense L.) phase II clinical extract. J Altern Complement Med 2006;12:133–139.
   PubMed Web of Science ®Google Scholar
• Jackson RL, Greiwe JS, Desai PB, Schwen RJ. Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor ß-agonist being developed for the treatment of menopausal symptoms. Menopause 2011;18:185–193.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Morales B, Hidalgo L. Depression and related risk factors among climacteric women. Climacteric 2008;11:125.
   Google Scholar
• Juang KD, Wang SJ, Lu SR, Lee SJ, Fuh JL. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas 2005;52:119–126.
   PubMed Web of Science ®Google Scholar